Open-label Study to Assess the Safety and Efficacy of CDP6038 in Patients Who Completed RA0056
This study has been completed.
UCB BIOSCIENCES, Inc.
First Posted: February 15, 2011
Last Update Posted: October 12, 2017
Information provided by (Responsible Party):
UCB Pharma ( UCB BIOSCIENCES, Inc. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||August 2013|
|Primary Completion Date:||May 2013 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||June 3, 2013|